These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 25682807
1. C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways. Maeda Y, Kawano Y, Wada Y, Yatsuda J, Motoshima T, Murakami Y, Kikuchi K, Imamura T, Eto M. Oncol Rep; 2015 Apr; 33(4):1844-50. PubMed ID: 25682807 [Abstract] [Full Text] [Related]
2. Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88). Nitta H, Wada Y, Kawano Y, Murakami Y, Irie A, Taniguchi K, Kikuchi K, Yamada G, Suzuki K, Honda J, Wilson-Morifuji M, Araki N, Eto M, Baba H, Imamura T. Clin Cancer Res; 2013 Apr 15; 19(8):2004-13. PubMed ID: 23287562 [Abstract] [Full Text] [Related]
6. Enrichment of C5a-C5aR axis predicts poor postoperative prognosis of patients with clear cell renal cell carcinoma. Xi W, Liu L, Wang J, Xia Y, Bai Q, Xiong Y, Qu Y, Long Q, Xu J, Guo J. Oncotarget; 2016 Dec 06; 7(49):80925-80934. PubMed ID: 27821813 [Abstract] [Full Text] [Related]
7. Complement C5a/C5aR pathway potentiates the pathogenesis of gastric cancer by down-regulating p21 expression. Chen J, Li GQ, Zhang L, Tang M, Cao X, Xu GL, Wu YZ. Cancer Lett; 2018 Jan 01; 412():30-36. PubMed ID: 29031586 [Abstract] [Full Text] [Related]
9. Functional identification of the stable transfection C5aR cell line Molt-4. Zhang C, Xu R, Wang J, Han G, Chen G, Wang R, Wei H, Shen B, Ma Y, Li Y. Cell Mol Immunol; 2007 Dec 01; 4(6):461-5. PubMed ID: 18163958 [Abstract] [Full Text] [Related]
10. The role of the ribosomal protein S19 C-terminus in Gi protein-dependent alternative activation of p38 MAP kinase via the C5a receptor in HMC-1 cells. Nishiura H, Tokita K, Li Y, Harada K, Woodruff TM, Taylor SM, Nsiama TK, Nishino N, Yamamoto T. Apoptosis; 2010 Aug 01; 15(8):966-81. PubMed ID: 20473571 [Abstract] [Full Text] [Related]
12. Expression of the anaphylatoxin C5a receptor in gastric cancer: implications for vascular invasion and patient outcomes. Nitta H, Shimose T, Emi Y, Imamura T, Ohnishi K, Kusumoto T, Yamamoto M, Fukuzawa K, Takahashi I, Higashi H, Tsuji A, Akagi Y, Oki E, Maehara Y, Baba H, Kyushu Study Group of Clinical Cancer (KSCC) ancillary study. Med Oncol; 2016 Nov 01; 33(11):118. PubMed ID: 27688239 [Abstract] [Full Text] [Related]
13. C5aR deficiency attenuates the breast cancer development via the p38/p21 axis. Chen J, Sun ZH, Chen LY, Xu F, Zhao YP, Li GQ, Tang M, Li Y, Zheng QY, Wang SF, Yang XH, Wu YZ, Xu GL. Aging (Albany NY); 2020 Jul 15; 12(14):14285-14299. PubMed ID: 32669478 [Abstract] [Full Text] [Related]
18. C5a/C5aR pathway accelerates renal ischemia-reperfusion injury by downregulating PGRN expression. Zhang K, Li GQ, He QH, Li Y, Tang M, Zheng QY, Xu GL, Zhang KQ. Int Immunopharmacol; 2017 Dec 15; 53():17-23. PubMed ID: 29031143 [Abstract] [Full Text] [Related]